Sugi Predict

Sugi Predict / Compounds / SCHEMBL16705772

SCHEMBL16705772

SCHEMBL16705772

CCCCCCCC(O)C(O)CCCCCCCCC(=O)CCCCCCCCO[Si](c1ccccc1)(c1ccccc1)C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 5/20 0.41
▸ PPARA Q07869 3/20 0.39
▸ CSNK1E P49674 1/20 0.38
▸ HDAC8 Q9BY41 4/20 0.38
▸ HDAC3 O15379 2/20 0.38
▸ HDAC6 Q9UBN7 2/20 0.38
▸ HDAC1 Q13547 1/20 0.38
▸ HDAC2 Q92769 1/20 0.38
▸ PRSS1 P07477 1/20 0.37
▸ CTSG P08311 1/20 0.37
▸ CTRB1 P17538 1/20 0.37
▸ CMA1 P23946 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ ASAH1 Q13510 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ CES2 O00748 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29113338 0.92 MAPT (0.41) HDAC6TSHRALDH1A1LMNACES2
SCHEMBL29689176 0.92 MAPT (0.41) HDAC6TSHRALDH1A1LMNACES2
SCHEMBL16705773 0.85 SOAT2 (0.47) PPARGPPARATSHRALDH1A1LMNA
SCHEMBL29113327 0.85 CSNK1E (0.38) PPARGCSNK1EPRSS1CTSGCTRB1
SCHEMBL12799225 0.84 CES2 (0.39) SMN1; SMN2TSHRALDH1A1CES2CES1
SCHEMBL16705769 0.83 EPHX2 (0.47) PPARGPPARATSHRALDH1A1LMNA
SCHEMBL16705777 0.83 TBXA2R (0.41) PPARAHDAC8HDAC3HDAC6HDAC1
SCHEMBL16520377 0.83 CSNK1E (0.37) CSNK1ENPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL18642002 0.83 ALDH1A1 (0.46) PPARGPPARAHDAC8HDAC3HDAC6
SCHEMBL25285339 0.82 TBXA2R (0.40) PPARAHDAC8HDAC3HDAC6HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170135962-A1 NOVEL DIESTER AND TRIESTER BASED LOW MOLECULAR WEIGHT, BIODEGRADEABLE CATIONIC LIPIDS FOR OLIGONUCLEOTIDE DELIVERY SIRNA THERAPEUTICS, INC. (US) 2017-05-18 — — US disclosed
US-9402816-B2 Diester and triester based low molecular weight, biodegradeable cationic lipids for oligonucleotide delivery SIMA THERAPEUTICS, INC. (US) 2016-08-02 — — US disclosed
US-20150133519-A1 NOVEL DIESTER AND TRIESTER BASED LOW MOLECULAR WEIGHT, BIODEGRADEABLE CATIONIC LIPIDS FOR OLIGONUCLEOTIDE DELIVERY BANK OF AMERICA, N.A. 2015-05-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150133519-A1 NOVEL DIESTER AND TRIESTER BASED LOW MOLECULAR WEIGHT, BIODEGRADEABLE CATIONIC LIPIDS FOR OLIGONUCLEOTIDE DELIVERY CYP46A1, CETP, LIPC PPARG 1750/4885PPARA 700/4885CSNK1E 1878/4885
US-20170135962-A1 NOVEL DIESTER AND TRIESTER BASED LOW MOLECULAR WEIGHT, BIODEGRADEABLE CATIONIC LIPIDS FOR OLIGONUCLEOTIDE DELIVERY CYP46A1, CETP, LIPC PPARG 1750/4885PPARA 700/4885CSNK1E 1878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.